Lexicon Pharmaceuticals Inc (LXRX)vsRevolution Medicines Inc (RVMD)
LXRX
Lexicon Pharmaceuticals Inc
$1.85
-2.12%
HEALTHCARE · Cap: $835.09M
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Lexicon Pharmaceuticals Inc generates 9286% more annual revenue ($69.64M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -37.5%. LXRX earns a higher WallStSmart Score of 29/100 (F).
LXRX
Avoid29
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 1572.0% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Smaller company, higher risk/reward
ROE of -12.9% — below average capital efficiency
Earnings declined 63.4%
Negative free cash flow — burning cash
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LXRX
The strongest argument for LXRX centers on Revenue Growth, Debt/Equity. Revenue growth of 1572.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : LXRX
The primary concerns for LXRX are Market Cap, Return on Equity, EPS Growth.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
LXRX profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
LXRX is growing revenue faster at 1572.0% — sustainability is the question.
LXRX generates stronger free cash flow (-15M), providing more financial flexibility.
Bottom Line
LXRX scores higher overall (29/100 vs 24/100) and 1572.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lexicon Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?